Trials / Completed
CompletedNCT05434559
Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec
Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec: a Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 475 (actual)
- Sponsor
- prof dr Pieter Gillard · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective multicenter study analyzing data gathered from medical records and diabetes management platforms to assess the effect of using Insulin Degludec (Tresiba®) on measures of diabetes control. People with type 1 diabetes who switched to Insulin Degludec from another basal insulin between 1/5/2019 and 1/6/2021 will be included. Glycemic control from 12 months before the switch to Insulin Degludec will be compared to glycemic control of the 12 months after the switch.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin Degludec | Switch during standard routine care to Insulin Degludec. |
Timeline
- Start date
- 2022-02-20
- Primary completion
- 2022-10-31
- Completion
- 2022-10-31
- First posted
- 2022-06-28
- Last updated
- 2022-12-21
Locations
2 sites across 1 country: Belgium
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05434559. Inclusion in this directory is not an endorsement.